<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00153816</url>
  </required_header>
  <id_info>
    <org_study_id>5R01CA098286-03</org_study_id>
    <secondary_id>5R01CA098286-10</secondary_id>
    <nct_id>NCT00153816</nct_id>
  </id_info>
  <brief_title>Vitamin D/Calcium Polyp Prevention Study</brief_title>
  <official_title>Vitamin D/Calcium Polyp Prevention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extensive experimental and observational data suggest that intake of calcium and of vitamin D
      exert protective effects on colorectal neoplasia. Building on their previous work, the
      investigators will investigate the chemopreventive effect of vitamin D in the large bowel, to
      study whether calcium with vitamin D is more effective than calcium alone, and to confirm
      their positive finding regarding calcium. The goal of this study is the development of
      chemopreventive combinations that will reduce risk of colorectal neoplasia sufficiently to
      permit the lengthening of surveillance intervals in most patients and to clarify important
      issues regarding the mechanisms of colorectal carcinogenesis and chemoprevention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a double-blind, placebo-controlled trial of vitamin D and/or calcium
      supplementation for the prevention of large bowel adenomas. Subjects will be recruited from
      11 Study Centers in North America. Eligible subjects will have had at least one large bowel
      adenoma removed in the 4 months prior to study entry and no remaining polyps in the bowel
      after complete colonoscopic examination. Participants will be randomized in a partial 2 x 2
      factorial design to vitamin D (1000 IU/day), calcium carbonate (1200 mg elemental
      calcium/day), both agents, or placebo only (Full Factorial randomization). Women who decline
      to forego calcium supplementation will be randomized only to calcium alone or to calcium plus
      vitamin D (Two Arm randomization). Randomization will be stratified by gender, study center
      of recruitment, and anticipated follow-up interval (see below), and will be conducted
      separately for female subjects randomized only to vitamin D. We anticipate enrolling up to
      3000 participants to reach a total of up to 2400 randomized subjects. As safety measures,
      blood levels of calcium, creatinine, and 25-(OH)-vitamin D will be obtained at baseline and 1
      year after randomization, as well as 3 years after randomization for subjects with a 5-year
      surveillance cycle. Every six months after randomization subjects will complete a
      questionnaire regarding compliance with study agents, use of medications and vitamin/mineral
      supplements, illnesses, hospitalizations, and dietary intake of calcium and vitamin D. The
      primary endpoint of the study will be new adenomas detected on follow-up colonoscopy. These
      examinations are scheduled to occur either 3 years or 5 years after the qualifying
      examination, depending on the follow-up interval recommended by each patient's endoscopist.
      Some patients may, for medical reasons, have a colonoscopy at a time other than 3 or 5 years
      after the qualifying examination. Information from these exams will be included in analyses
      where appropriate. In the primary analyses, the occurrence of new adenomas in the interval
      between randomization and the follow-up exam will be compared between subjects randomized to
      vitamin D (with or without calcium) versus those randomized to no vitamin D (with or without
      calcium), between subjects randomized to calcium (with or without vitamin D) versus those
      randomized to no calcium (with or without vitamin D; excluding women electing to receive
      calcium who therefore cannot participate in the calcium component of the study), and between
      those randomized to calcium plus vitamin D versus those randomized to calcium alone. In
      secondary analyses, we will examine the impact of baseline vitamin D levels and vitamin D
      receptor (VDR) polymorphisms on the vitamin D effects. Effects on advanced adenomas will also
      be assessed as a secondary outcome. Participants will be invited to participate in an
      optional Observational Follow Up phase of the study that will begin following the end of
      treatment. In this phase of the study, subjects will continue to be followed on an
      observational basis (no study treatment) with annual questionnaires until the time of a
      subsequent colonoscopy that is at least three years from the follow up colonoscopy at which
      study treatment was ended. We will examine the occurrence of new adenomas in the interval
      between the colonoscopy exam at the end of study treatment and the exam at the end of
      observational follow up period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2004</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colorectal Adenomas</measure>
    <time_frame>1 to 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Advanced Colorectal Lesions</measure>
    <time_frame>1 to 10 years</time_frame>
    <description>Includes: adenomas &gt;=1 cm, adenomas with high grade dysplasia, adenomas with villous features, or cancer.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">2813</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Polyps</condition>
  <condition>Adenomas</condition>
  <arm_group>
    <arm_group_label>Full Factorial Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects in 2X2 factorial design; randomized to daily placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full Factorial Calcium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full Factorial Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full Factorial Calcium Plus Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two Arm Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two Arm Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Carbonate</intervention_name>
    <description>3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
    <arm_group_label>Full Factorial Calcium</arm_group_label>
    <arm_group_label>Full Factorial Calcium Plus Vitamin D</arm_group_label>
    <arm_group_label>Two Arm Placebo</arm_group_label>
    <arm_group_label>Two Arm Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>1000 IU/daily; two tablets per day; 500 IU per tablet</description>
    <arm_group_label>Full Factorial Vitamin D</arm_group_label>
    <arm_group_label>Full Factorial Calcium Plus Vitamin D</arm_group_label>
    <arm_group_label>Two Arm Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo; two tablets per day</description>
    <arm_group_label>Full Factorial Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One or more histologically verified neoplastic polyp (adenoma) that is at least 2 mm
             in size removed from the large bowel with the entire large bowel examined by
             colonoscopy and documented to be free of further polyps or areas suspicious for
             neoplasia within 120 days of study entry

          -  Anticipated colonoscopic follow-up three years or five years after the qualifying
             colonoscopy

          -  Age between 45 and 75 years at enrollment

          -  (Women)Agreement to avoid pregnancy (i.e., use of standard contraception)

          -  Willingness to forego calcium supplementation (including multivitamins containing
             calcium) or, for women only, option of taking calcium supplementation of 1200 mg/daily
             (contained in the study pills)

          -  Willingness to forego vitamin D supplementation (including multivitamins containing
             vitamin D)

          -  Agreement to daily dietary intake of the equivalent of not more than 1200 mg calcium

          -  Agreement to daily dietary intake of the equivalent of not more than 400 IU vitamin D

          -  Blood calcium level within normal range

          -  Blood creatinine level not to exceed 20% above upper limit of normal

          -  Serum 25-(OH)-vitamin D within lower limit of normal to 70 ng/ml

          -  Ability and willingness to follow the study protocol, as indicated by provision of
             informed consent to participate

          -  Good general health, with no severely debilitating diseases or active malignancy that
             might compromise the patient's ability to complete the study

        Exclusion Criteria:

        General exclusionary criteria:

          -  Participation in another colorectal (bowel) study (intervention study) in the past 5
             years

          -  Current participation in any other clinical trial (intervention study)

          -  Pregnancy or lactation

          -  A diagnosis of narcotic or alcohol dependence in the past 5 years

          -  A diagnosis of dementia (e.g. Alzheimer's) in the past 5 years

          -  A diagnosis of a significant psychiatric disability (e.g. Schizophrenia, refractory
             bipolar disorder, current severe depression) in the past 5 years

        Exclusions due to derangement of calcium metabolism or indications /contraindications to
        study agents:

          -  Any diagnosis of kidney stones

          -  A diagnosis of granulomatous diseases, e.g. sarcoidosis, active chronic fungal or
             mycobacterial infections (tuberculosis, histoplasmosis, coccidioidomycosis,
             blastomycosis), berylliosis, Wegener's granulomatosis in the past 5 years

          -  A diagnosis of hyperparathyroidism or other serious disturbance of calcium metabolism
             in the past 5 years

          -  A diagnosis of severe kidney disease, e.g. chronic renal failure in the past 5 years

          -  A diagnosis of unexplained hypercalcemia in the past 5 years

          -  Any Diagnosis of osteoporosis with physician recommendation for treatment of low bone
             mass

          -  A diagnosis of two or more low trauma fractures in the past 5 years

          -  A diagnosis of a medical condition requiring treatment with vitamin D (e.g.
             osteomalacia) in the past 5 years

        Exclusions due to intestinal or bowel problems:

          -  Any diagnosis of invasive carcinoma of the large bowel (even if confined to a polyp)

          -  Any diagnosis of familial colorectal cancer syndromes, e.g. Familial Adenomatous
             Polyposis (FAP) (including Gardner syndrome, Turcot's syndrome), Hereditary
             Nonpolyposis Colorectal Cancer (HNPCC), Hamartomatous Polyposis syndromes (including
             Peutz-Jeghers or Familial Juvenile Polyposis)

          -  Any diagnosis of inflammatory bowel disease, e.g. Crohn's Disease, Ulcerative Colitis

          -  A diagnosis of chronic intestinal malabsorption syndromes, e.g. celiac sprue,
             bacterial overgrowth, chronic pancreatitis, pancreatic insufficiency in the past 5
             years

          -  Any large bowel resection

        Exclusions due to poor health:

          -  A diagnosis of malignancy, other than non-melanoma skin cancer in the past 5 years

          -  A diagnosis of severe lung disease - class 3 or 4 (e.g. chronic obstructive pulmonary
             disease or emphysema requiring oxygen) in the past 5 years

          -  A diagnosis of severe heart disease: cardiovascular disease functional class 3 or 4 in
             the past 5 years

          -  Any diagnosis of severe liver disease, e.g. cirrhosis

        Exclusions due to shipping regulations:

          -  Any current/past HIV positive diagnosis

          -  Active hepatitis B, defined as : Hep B surface antigen positive

          -  Active hepatitis C, defined as : measurable hepatitis C RNA

        Drug exclusions:

          -  Use of chronic oral corticosteroid therapy in the past 5 years

          -  Use of lithium in the past 5 years

          -  Use of phenytoin's in the past 5 years

          -  Use of quinidine in the past 5 years

          -  Use of therapeutic vitamin D in the past 5 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John A. Baron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Puerto Rico</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <results_first_submitted>September 21, 2015</results_first_submitted>
  <results_first_submitted_qc>September 21, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 20, 2015</results_first_posted>
  <disposition_first_submitted>August 4, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>August 4, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 6, 2015</disposition_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal neoplasms</keyword>
  <keyword>Adenomatous polyps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were enrolled between July 2004 and July 2008 at 11 academic medical centers and associated gastroenterology practices in the U.S.</recruitment_details>
      <pre_assignment_details>19,083 subjects were screened and 2,813 were enrolled into a run-in period of 56-84 days. 554 subjects were not randomized: 174 were ineligible due to out of range baseline lab values, 66 were ineligible for other reasons, 211 had &lt;80% tablet adherence, and 103 refused to participate.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Full Factorial Placebo</title>
          <description>subjects in 2X2 factorial design; randomized to daily placebo
placebo: placebo; two tablets per day</description>
        </group>
        <group group_id="P2">
          <title>Full Factorial Calcium</title>
          <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="P3">
          <title>Full Factorial Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="P4">
          <title>Full Factorial Calcium Plus Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="P5">
          <title>Two Arm Placebo</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="P6">
          <title>Two Arm Vitamin D</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="415"/>
                <participants group_id="P2" count="419"/>
                <participants group_id="P3" count="420"/>
                <participants group_id="P4" count="421"/>
                <participants group_id="P5" count="295"/>
                <participants group_id="P6" count="289"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="383"/>
                <participants group_id="P2" count="387"/>
                <participants group_id="P3" count="388"/>
                <participants group_id="P4" count="390"/>
                <participants group_id="P5" count="278"/>
                <participants group_id="P6" count="262"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="32"/>
                <participants group_id="P4" count="31"/>
                <participants group_id="P5" count="17"/>
                <participants group_id="P6" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="7"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Follow-up exam not done</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Follow-up exam done, histology missing</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Full Factorial Placebo</title>
          <description>subjects in 2X2 factorial design; randomized to daily placebo
placebo: placebo; two tablets per day</description>
        </group>
        <group group_id="B2">
          <title>Full Factorial Calcium</title>
          <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="B3">
          <title>Full Factorial Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="B4">
          <title>Full Factorial Calcium Plus Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="B5">
          <title>Two Arm Placebo</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="B6">
          <title>Two Arm Vitamin D</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="415"/>
            <count group_id="B2" value="419"/>
            <count group_id="B3" value="420"/>
            <count group_id="B4" value="421"/>
            <count group_id="B5" value="295"/>
            <count group_id="B6" value="289"/>
            <count group_id="B7" value="2259"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.2" spread="7.0"/>
                    <measurement group_id="B2" value="58.7" spread="7.0"/>
                    <measurement group_id="B3" value="58.3" spread="7.0"/>
                    <measurement group_id="B4" value="58.7" spread="6.9"/>
                    <measurement group_id="B5" value="56.7" spread="6.0"/>
                    <measurement group_id="B6" value="57.0" spread="6.6"/>
                    <measurement group_id="B7" value="58.1" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="67"/>
                    <measurement group_id="B5" value="295"/>
                    <measurement group_id="B6" value="289"/>
                    <measurement group_id="B7" value="836"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="355"/>
                    <measurement group_id="B2" value="356"/>
                    <measurement group_id="B3" value="358"/>
                    <measurement group_id="B4" value="354"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1423"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="26"/>
                    <measurement group_id="B7" value="146"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="395"/>
                    <measurement group_id="B2" value="395"/>
                    <measurement group_id="B3" value="396"/>
                    <measurement group_id="B4" value="394"/>
                    <measurement group_id="B5" value="267"/>
                    <measurement group_id="B6" value="263"/>
                    <measurement group_id="B7" value="2110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="46"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="25"/>
                    <measurement group_id="B7" value="184"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="357"/>
                    <measurement group_id="B2" value="354"/>
                    <measurement group_id="B3" value="364"/>
                    <measurement group_id="B4" value="350"/>
                    <measurement group_id="B5" value="238"/>
                    <measurement group_id="B6" value="237"/>
                    <measurement group_id="B7" value="1900"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="20"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Puerto Rico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="408"/>
                    <measurement group_id="B2" value="412"/>
                    <measurement group_id="B3" value="413"/>
                    <measurement group_id="B4" value="414"/>
                    <measurement group_id="B5" value="290"/>
                    <measurement group_id="B6" value="285"/>
                    <measurement group_id="B7" value="2222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Colorectal Adenomas</title>
        <time_frame>1 to 10 years</time_frame>
        <population>Subjects are included if they had a follow-up exam at least one year after randomization and had sufficient histology available to ascertain the endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Full Factorial Placebo</title>
            <description>subjects in 2X2 factorial design; randomized to daily placebo
placebo: placebo; two tablets per day</description>
          </group>
          <group group_id="O2">
            <title>Full Factorial Calcium</title>
            <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
          </group>
          <group group_id="O3">
            <title>Full Factorial Vitamin D</title>
            <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
          <group group_id="O4">
            <title>Full Factorial Calcium Plus Vitamin D</title>
            <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
          <group group_id="O5">
            <title>Two Arm Placebo</title>
            <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
          </group>
          <group group_id="O6">
            <title>Two Arm Vitamin D</title>
            <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Colorectal Adenomas</title>
          <population>Subjects are included if they had a follow-up exam at least one year after randomization and had sufficient histology available to ascertain the endpoint.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="381"/>
                <count group_id="O3" value="381"/>
                <count group_id="O4" value="381"/>
                <count group_id="O5" value="274"/>
                <count group_id="O6" value="262"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.2" lower_limit="43.0" upper_limit="53.3"/>
                    <measurement group_id="O2" value="44.9" lower_limit="39.8" upper_limit="50.0"/>
                    <measurement group_id="O3" value="47.0" lower_limit="41.9" upper_limit="52.1"/>
                    <measurement group_id="O4" value="45.7" lower_limit="40.6" upper_limit="50.8"/>
                    <measurement group_id="O5" value="32.1" lower_limit="26.6" upper_limit="38.0"/>
                    <measurement group_id="O6" value="32.4" lower_limit="26.8" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Advanced Colorectal Lesions</title>
        <description>Includes: adenomas &gt;=1 cm, adenomas with high grade dysplasia, adenomas with villous features, or cancer.</description>
        <time_frame>1 to 10 years</time_frame>
        <population>Subjects are included if they had a follow-up exam at least one year after randomization and sufficient histology available to ascertain the endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Full Factorial Placebo</title>
            <description>subjects in 2X2 factorial design; randomized to daily placebo
placebo: placebo; two tablets per day</description>
          </group>
          <group group_id="O2">
            <title>Full Factorial Calcium</title>
            <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
          </group>
          <group group_id="O3">
            <title>Full Factorial Vitamin D</title>
            <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
          <group group_id="O4">
            <title>Full Factorial Calcium Plus Vitamin D</title>
            <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
          <group group_id="O5">
            <title>Two Arm Placebo</title>
            <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
          </group>
          <group group_id="O6">
            <title>Two Arm Vitamin D</title>
            <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Advanced Colorectal Lesions</title>
          <description>Includes: adenomas &gt;=1 cm, adenomas with high grade dysplasia, adenomas with villous features, or cancer.</description>
          <population>Subjects are included if they had a follow-up exam at least one year after randomization and sufficient histology available to ascertain the endpoint.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="386"/>
                <count group_id="O3" value="384"/>
                <count group_id="O4" value="387"/>
                <count group_id="O5" value="276"/>
                <count group_id="O6" value="261"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" lower_limit="6.5" upper_limit="12.6"/>
                    <measurement group_id="O2" value="11.4" lower_limit="8.4" upper_limit="15.0"/>
                    <measurement group_id="O3" value="10.9" lower_limit="8.0" upper_limit="14.5"/>
                    <measurement group_id="O4" value="9.6" lower_limit="6.8" upper_limit="12.9"/>
                    <measurement group_id="O5" value="6.9" lower_limit="4.2" upper_limit="10.5"/>
                    <measurement group_id="O6" value="7.3" lower_limit="4.4" upper_limit="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Events are included if they occur between randomization and 30 days after the subject exits the treatment phase of the trial, roughly 3 or 5 years after study entry, depending on when their next surveillance colonoscopy is expected.</time_frame>
      <desc>Every 6 months, subjects were asked to report all hospitalizations and contacts with medical services. All events have been confirmed via medical record review by a study physician.</desc>
      <group_list>
        <group group_id="E1">
          <title>Full Factorial Placebo</title>
          <description>subjects in 2X2 factorial design; randomized to daily placebo
placebo: placebo; two tablets per day</description>
        </group>
        <group group_id="E2">
          <title>Full Factorial Calcium</title>
          <description>subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="E3">
          <title>Full Factorial Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1000 IU vitamin D3
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="E4">
          <title>Full Factorial Calcium Plus Vitamin D</title>
          <description>Subjects in 2X2 factorial design; randomized to daily 1200 mg as calcium carbonate and 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
        <group group_id="E5">
          <title>Two Arm Placebo</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily placebo
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet</description>
        </group>
        <group group_id="E6">
          <title>Two Arm Vitamin D</title>
          <description>Women choosing to take daily 1200 mg as calcium carbonate randomized to daily 1000 IU vitamin D3
Calcium Carbonate: 3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3: 1000 IU/daily; two tablets per day; 500 IU per tablet</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="84" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="94" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="97" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="80" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="64" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="63" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cardiac ischemia/myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Congestive heart failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Valvular heart disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Cochlear implant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroid disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Thyroid hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Colostomy take-down</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Gastroesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hiatal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Ischemic colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Gastrointestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol intoxication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Altered mental status</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Altitude sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Deviated septum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Febrile Illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Groin hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Multiple illnesses</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Sleep apnea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Syncope/near syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Toxic shock syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Traumatic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Bacteremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Febrile Illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Glottitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Infected prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Upper respiratory infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Postoperative hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Sigmoid perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Subdural hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Unintentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Motor vehicle accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Electrolyte disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Flat feet</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Gout/rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Joint replacement</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Nerve entrapment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Traumatic injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Ventral hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Back pain/degenerative spinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Benign parotid tumor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Biliary cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Breast cancer/ductal carcinoma in situ</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Carcinoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Central nervous system cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Endometrial cancer/hyperplasia</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Espohageal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Head and neck neoplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Kidney cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Lymphoma/leukemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Oncocytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pancreatic cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Peritoneal mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Prostate and bladder cancer</sub_title>
                <description>Only men are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="355"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="356"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="358"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="354"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <description>Only men are considered at risk</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="355"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="356"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="358"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="354"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Serous ovarian tumor of low malignant potential</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Skin basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Thymoma type AB</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Central nervous system cerebrovascular ischemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cerebral spinal fluid leak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hygroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Migraine syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Traumatic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Vestibular neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Bipolar affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Steroid psychosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cystocele/rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Urolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <description>Only men are considered at risk</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="355"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="356"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="358"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="354"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Breast surgery</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Corpus luteum cyst</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Fibroids</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pubovaginal sling</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Vaginal bleeding</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <description>Only women are considered at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Traumatic injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cosmetic surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Cerebrovascular ischemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Revascularization</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Subdural hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Traumatic injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Venous thromboembolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="47" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="61" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="53" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="40" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="289"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Non-melanoma skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="415"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="419"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="420"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="421"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="295"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="289"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hypercreatinemia</sub_title>
                <description>Hypercreatinemia is a value on a safety blood draw above normal for subjects whose baseline creatinine was normal. Only subjects who had at least one safety blood draw are included.</description>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="407"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="412"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="415"/>
                <counts group_id="E4" subjects_affected="29" subjects_at_risk="413"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="294"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="287"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Leila A. Mott, Statistical Analyst</name_or_title>
      <organization>Geisel School of Medicine at Dartmouth</organization>
      <phone>603-650-3447</phone>
      <email>Leila.A.Mott@Dartmouth.EDU</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

